ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $84,000 | +42.4% | 69,954 | +55.9% | 0.00% | – |
| Q1 2022 | $59,000 | -31.4% | 44,878 | -8.6% | 0.00% | – |
| Q4 2021 | $86,000 | +19.4% | 49,107 | +47.9% | 0.00% | – |
| Q3 2021 | $72,000 | -95.4% | 33,199 | -92.6% | 0.00% | -100.0% |
| Q2 2021 | $1,567,000 | -72.5% | 447,785 | -22.4% | 0.01% | -74.4% |
| Q1 2021 | $5,689,000 | +511.7% | 577,012 | +572.3% | 0.04% | +333.3% |
| Q4 2020 | $930,000 | -43.7% | 85,825 | -46.5% | 0.01% | -55.0% |
| Q3 2020 | $1,652,000 | +128.5% | 160,347 | +363.1% | 0.02% | +100.0% |
| Q2 2020 | $723,000 | +487.8% | 34,621 | +174.0% | 0.01% | +100.0% |
| Q1 2020 | $123,000 | -90.0% | 12,634 | -88.2% | 0.01% | -73.7% |
| Q4 2019 | $1,236,000 | -39.6% | 107,291 | -71.4% | 0.02% | -40.6% |
| Q3 2019 | $2,048,000 | +304.7% | 375,697 | +782.4% | 0.03% | +255.6% |
| Q2 2019 | $506,000 | – | 42,576 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 420,000 | $1,134,000 | 0.67% |
| EcoR1 Capital, LLC | 874,447 | $2,361,000 | 0.60% |
| VHCP Management II, LLC | 280,000 | $756,000 | 0.31% |
| 683 Capital Management, LLC | 350,000 | $945,000 | 0.15% |
| AWM Investment Company, Inc. | 400,000 | $1,080,000 | 0.10% |
| JW Asset Management, LLC | 178,654 | $482,000 | 0.10% |
| TFS CAPITAL LLC | 89,156 | $241,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 154,006 | $416,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 282,630 | $763,000 | 0.04% |
| Numeric Investors LLC | 1,087,967 | $2,938,000 | 0.03% |